A subsidiary of a Miami-based company is inching closer to FDA approval for a drug that treats a rare pediatric disease.

The new prefilled syringe has the same composition but removes the need for reconstitution, providing a more convenient option for health care providers who administer vaccines. According to the ...

The prosecutor-led program continues her look into juvenile justice. It also continues a state-wide examination of the impact ...

Pacira BioSciences, Inc. (Nasdaq: PCRX), the industry leader in its commitment to deliver innovative, non-opioid pain therapies to transform the lives of patients, today announced its five-year growth ...

Grieving parents of children killed by fentanyl pills say the Trump administration has the potential to address the nation's drug epidemic.

Phase 2 clinical study of firicabtagene autoleucel (firi-cel); Interim analysis results expected to be reported in 1H'25 - - IND application for CRG-023 ...

Mural nominated two new development candidates, MURA-8518 a novel binding protein-resistant IL-18 with half-life extension, and MURA-7012, targeted split sub-units of IL-12; Mural anticipates an IND ...

This week, the FDA granted priority review status to J&J’s JNJ application seeking approval of key pipeline candidate ...

Consumer Electronics Show CES the world premier tech show concluded in the US city of Las Vegas on Friday showcasing latest advancemen ...

In the span of eight months, Big Pharma companies took over four of the hottest radiopharmaceutical players in the industry.

Governor Jared Polis delivered his 2025 State of the State address before the state legislature on Thursday morning, ...

Once confined to the province of abstract theory, quantum computing seeks to use operations based on quantum mechanics to ...